References
- Knowles B, Rappaport J, Solter D. Murine embryonic antigen (SSEA-1) is expressed on human cells and structurally related human blood group antigen I is expressed on mouse embryos. Developmental Biol. 1982;93(1):54–57. doi:https://doi.org/10.1016/0012-1606(82)90238-X.
- Hakomori S, Nudelman ED, Levery SB, Kannagi R. Novel fucolipids accumulating inhuman adenocarcinoma: I. Glycolipids with di- or trifucosylated type 2 chain. J Biol Chem. 1984;259(7):4672–4680. doi:https://doi.org/10.1016/S0021-9258(17)43099-7.
- Hakomori SI. Le(X) and related structures as adhesion molecules. Histochem J. 1992;24(11):771–776. doi:https://doi.org/10.1007/BF01046348.
- Elola MT, Capurro MI, Barrio MM, Coombs PT, Taylor ME, Drickamer K, Mordoh J. Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin. Breast Cancer Res Treat. 2007;101(2):161–174. doi:https://doi.org/10.1007/s10549-006-9286-9.
- Hakomori S, Nudelman E, Levery S, Solter D, Knowles BB. The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note. Biochem Biophys Res Commun. 1981;100(4):1578–1586. doi:https://doi.org/10.1016/0006-291x(81)90699-9.
- Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ. Stage-specific Embryonic Antigen Involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature. 1981;292(5819):156–158. doi:https://doi.org/10.1038/292156a0.
- Kerr MA, Stocks SC. The Role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion . Histochem J. 1992;24(11):811–826. doi:https://doi.org/10.1007/BF01046353.
- Heimburg-Molinaro J, Lum M, Vijay G, Jain M, Almogren A, Rittenhouse-Olson K. Cancer vaccines and carbohydrate epitopes. Vaccine. 2011;29(48):8802–8826. doi:https://doi.org/10.1016/j.vaccine.2011.09.009.
- Hakomori S-I. Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin Haematol. 1981;18(1):39–62.
- Feizi T, Childs RA. Carbohydrates as antigenic determinants of glycoproteins. Biochem J. 1987;245(1):1–11. doi:https://doi.org/10.1042/bj2450001.
- Kannagi R, Yin J, Miyazaki K, Izawa M. Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori’s concepts revisited. Biochim Biophys Acta. 2008;1780(3):525–531. doi:https://doi.org/10.1016/j.bbagen.2007.10.007.
- Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978;75(11):5565–5569. doi:https://doi.org/10.1073/pnas.75.11.5565.
- Fox N, Damjanov I, Knowles BB, Solter D. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res. 1983;43(2):669–678.
- Spooncer E, Fukuda M, Klock JC, Oates JE, Dell A. Isolation and characterization of polyfucosylated lactosaminoglycan from human granulocytes. J Biol Chem. 1984;259(8):4792–4801. doi:https://doi.org/10.1016/S0021-9258(17)42916-4.
- Nakayama F, Nishihara S, Iwasaki H, Kudo T, Okubo R, Kaneko M, et al. CD15 Expression in Mature Granulocytes Is Determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV. J Biol Chem. 2001; 276(19):16100–16106. doi:https://doi.org/10.1074/jbc.M007272200.
- Fukushi Y, Hakomori S, Shepard T. Localization and alteration of mono-, di-, and trifucosyl alpha 1. J Exp Med. 1984;160(2):506–520. doi:https://doi.org/10.1084/jem.160.2.506.
- Uchida E, Steplewski Z, Mroczek E, Buchler M, Burnett D, Pour PM. Presence of two distinct acinar cell populations in human pancreas based on their antigenicity. Int J Pancreatol. 1986;1(3–4):213–225. doi:https://doi.org/10.1007/BF02795247.
- Philipsen EK, Jørgensen M, Dabelsteen E. Expression of blood group-related carbohydrate antigens in normal human pancreatic tissue. APMIS. 1991;99(10):931–940. doi:https://doi.org/10.1111/j.1699-0463.1991.tb01281.x.
- Croce MV, Isla Larrain MT, Rabassa ME, Demichelis S, Colussi AG, Crespo M, et al. Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision. Pathol Oncol Res. 2007;13(2):130–138. doi:https://doi.org/10.1007/BF02893488.
- Demichelis SO, Alberdi CG, Servi W, Isla Larrain MT, Segal-Eiras A, Croce MV. Comparative immunohistochemical study of MUC1 and carbohydrate antigens in breast benign disease and normal mammary gland. Appl Immunohistoch Mol Morphol. 2010;18(1):41–50. doi:https://doi.org/10.1097/PAI.0b013e3181ac1c20.
- Demichelis SO, Isla-Larrain M, Cermignani L, Alberdi CG, Segal-Eiras A, Croce MV. Invasive breast cancer in argentine women: association between risk and prognostic factors with antigens of peptídic and carbohydrate nature. Breast Cancer Targets and Ther. 2011;3:1–13.
- Ball ED, Schwarz LM, Bloomfield CD. Expression of the CD15 antigen on normal and leukemic myeloid cells: effects of neuraminidase and variable detection with a panel of monoclonal antibodies. Mol Immunol. 1991;28(9):951–958. doi:https://doi.org/10.1016/0161-5890(91)90180-r.
- Derolf AR, Björklund E, Mazur J, Björkholm M, Porwit A. Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia. Leuk Lymphoma. 2008;49(7):1279–1291. doi:https://doi.org/10.1080/10428190802123994.
- Shi ZR, Mc Intyre LJ, Knowles BB, Solter R, Kim YS. Expression of a carbohydrate differentiation antigen, stage-specific embryonic antigen 1, in human colonic adenocarcinoma. Cancer Res. 1984;44(3):1142–1147.
- Gong E, Hirohashi S, Shimosato Y, Watanabe M, Ino Y, Teshima S, Kodaira S. Expression of carbohydrate antigen 19-9 and stage-specific embryonic antigen 1 in nontumorous and tumorous epithelia of the human colon and rectum. J Natl Cancer Inst. 1985;75(3):447–454.
- Itzkowitz SH, Shi ZR, Kim YS. Heterogeneous expression of two oncodevelopmental antigens, CEA and SSEA-1, in colorectal cancer. Histochem J. 1986;18(4):155–163. doi:https://doi.org/10.1007/BF01676115.
- Marcial MA, Gonalez A, Ramon-Ruiz E. Colorectal carcinoma: a pathologic and immunopathologic study. P R Health Sci J. 1983;12:183–187.
- Watson SA, Morris TM, Crosbee DM, Hardcastle JD. A hepatic invasive human colorectal xenograft model. Eur J Cancer. 1993;29(12):1740–1745. doi:https://doi.org/10.1016/0959-8049(93)90117-X.
- Nakagoe T, Fukushima K, Hirota M, Kusano H, Ayabe H, Tomita M, Kamihira S. An immunohistochemical employer monoclonal antibodies against Le(a), sialyl Le(a), Le(x), and sialyl Le(x) antigens in primary colorectal, carcinomas and lymph node and hepatic lesions. J Gastroenterol. 1994;29(2):129–138. doi:https://doi.org/10.1007/BF02358673.
- Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res. 1986;46(5):2619–2626.
- Kim YS, Itzkowitz SH, Yuan M, Chung Y, Satake K, Umeyama K, Hakomori S. Lex and Ley antigen expression in human pancreatic cancer. Cancer Res. 1988;48(2):475–482.
- Pour PM, Tempero MM, Takasaki H, Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Expression of blood group-related Antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient’s blood group type1. Cancer Res. 1988;48:5422–5426.
- Ichihara T, Sakamoto J, Nakao A, Furukawa K, Watanabe T, Suzuki N, et al. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein. Cancer (Phila). 1993;71(1):71–81. doi:https://doi.org/10.1002/1097-0142(19930101)71:1<71::AID-CNCR2820710113>3.0.CO;2-4.
- Remmers N, Anderson JM, Linde EM, Di Maio DJ, Lazenby AJ, Wandall HH, et al. Aberrant expression of mucin core proteins and O-linked glycans associated with progression of pancreatic cancer. Clin Cancer Res. 2013;19(8):1981–1993. doi:https://doi.org/10.1158/1078-0432.CCR-12-2662.
- Shirahama T, Ikoma M, Muramatsu T, Ohi Y. Expression of SSEA-1 carbohydrate antigen correlates with stage, grade and metastatic potential of transitional cell carcinoma of the bladder. J Urol. 1992; 148(4):1319–1322. doi:https://doi.org/10.1016/S0022-5347(17)36900-8.
- Konety BR, Ballou B, Jaffe R, Singh J, Reiland J, Hakala TR. Expression of SSEA-1 (Lewis(x)) on transitional cell carcinoma of the bladder. Urol Int. 1997;58(2):69–74. doi:https://doi.org/10.1159/000282953.
- Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, et al. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol. 1990;143(2):285–288. doi:https://doi.org/10.1016/s0022-5347(17)39935-4.
- Masmiquel L, Castro-Forns M, de Torres I, Garcia A, Vidal MT, Simo R. Leu-M1 immunoreactivity and phaeochromocytoma. J Clin Pathol. 1997;50(2):168–170. doi:https://doi.org/10.1136/jcp.50.2.168.
- Neuhold N, Langle F, Gnant M, Hollenstein U, Niederle B. Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma. J Cancer Res Clin Oncol. 1992;118(8):629–634. doi:https://doi.org/10.1007/BF01211810.
- Schröder S, Schwarz W, Rehpenning W, Dralle H, Bay V, Böcker W. Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland. J Cancer Res Clin Oncol. 1988;114(3):291–296. doi:https://doi.org/10.1007/BF00405836.
- Schröder S, Schwarz W, Rehpenning W, Löning T, Böcker W. Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch A Pathol Anat Histopathol. 1987;411(5):435–439. doi:https://doi.org/10.1007/BF00735224.
- Kadota A, Masutani M, Takei M, Horie T. Evaluation of expression of CD15 and sCD15 in non-small cell lung cancer. Int J Oncol. 1999;15:1081–1089. doi:https://doi.org/10.3892/ijo.15.6.1081.
- Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, et al. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell. 2009;15(2):135–147. doi:https://doi.org/10.1016/j.ccr.2008.12.016.
- Ernst CS, Shen J-W, Litwin S, Herlyn M, Koprowski H, Sears HE. Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma. J Natl Cancer Inst. 1986;77(2):387–395.
- Hoff SD, Irimura T, Matsushita Y, Ota DM, Cleary KR, Hakomori S. Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens . Arch Surg. 1990;125(2):206–209. doi:https://doi.org/10.1001/archsurg.1990.01410140084013.
- Nakamori S, Kameyama M, Imaoka S. Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 1993;53(15):3632–3637.
- Miyake M, Taki T, Hitomi S, Hakomori S. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med. 1992; 327(1):14–18. doi:https://doi.org/10.1056/NEJM199207023270103.
- Torii A, Nakayama A, Harada A, Nakao A, Nonami T, Sakamoto J, et al. Expression of the CD15 antigen in hepatocellular carcinoma. Cancer. 1993;71(12):3864–3867. doi:https://doi.org/10.1002/1097-0142(19930615)71:12<3864::AID-CNCR2820711212>3.0.CO;2-5.
- Yasmin-Karim S, King MR, Messing EM, Lee YF. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis. Oncotarget. 2014;5(23):12097–12110. doi:https://doi.org/10.18632/oncotarget.2503.
- Mao X-G, Zhang X, Xue X-Y, Guo G, Wang P, Zhang W, et al. Brain tumor stem-like cells identified by neural stem cell marker CD15. Transl Oncol. 2009;2(4):247–257. doi:https://doi.org/10.1593/tlo.09136.
- Hammerich KH, Ayala GE, Wheeler TM. Application of immunohistochemistry to the genitourinary system (prostate, orinary bladder, testis, and kidney). Arch Pathol Lab Med. 2008;132(3):432–440. doi:https://doi.org/10.5858/2008-132-432-AOITTG.
- Jassam SA, Maherally Z, Smith JR, Ashkan K, Roncaroli F, Fillmore HL, Pilkington GJ. TNF-α enhancement of CD62E mediates adhesion of non-small cell lung cancer cells to brain endothelium via CD15 in lung-brain metastasis. Neuro Oncol. 2016;18(5):679–690. doi:https://doi.org/10.1093/neuonc/nov248.
- Croce MV, Rabassa ME, Price MR, Segal-Eiras A. MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma. Pathol Oncol Res. 2001;7(4):284–291. doi:https://doi.org/10.1007/BF03032385.
- Croce MV, Rabassa ME, Pereyra A, Segal-Eiras A. Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma. Head Neck. 2008; 30(5):647–657. doi:https://doi.org/10.1002/hed.20756.
- Rabassa ME, Pereyra A, Pereyra L, Segal-Eiras A, Abba MC, Croce MV. Lewis x antigen is associated to head and Neck Squamous Cell Carcinoma Survival. Pathol Oncol Res. 2018;24(3):525–531. doi:https://doi.org/10.1007/s12253-017-0269-4.
- Brooks SA, Leathem AJ. Expression of the CD15 antigen (Lewis x) in breast cancer. Histochem J. 1995;27(9):689–93.
- Narita T, Funahashi H, Satoh Y, Watanabe T, Takagi H, Sakamoto J. Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer. 1993;71(10):3044–3051. doi:https://doi.org/10.1002/1097-0142(19930515)71:10<3044::AID-CNCR2820711026>3.0.CO;2-R.
- Gendler S. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6(3):339–353. doi:https://doi.org/10.1023/A:1011379725811.
- Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9(12):874–885. doi:https://doi.org/10.1038/nrc2761.
- Lloyd K, Burchell J, Kudryashov V, Yin BWT, Taylor-Papadimitriou J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem. 1996;271(52):33325–33334. doi:https://doi.org/10.1074/jbc.271.52.33325.
- Burchell JM, Mungul A, Taylor-Papadimitriou J. O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia. 2001;6(3):355–364. doi:https://doi.org/10.1023/A:1011331809881.
- Ho JJ, Siddiki B, Kim YS. Association of Sialyl-Lewis a and Sialyl-Lewis x with MUC-1 apomucin in a pancreatic cancer cell line1. Cancer Res. 1995;55(16):3659–3663.
- Luna A, Rabassa ME, Isla Larrain M, Cabaleiro P, Zwenger A, Canzoneri R, et al. Breast cancer cutaneous metastases are associated to uMUC1 and sialyl Lewis x and to highly malignant primary tumors. Pathol Res Practice. 2020;216 (4):152859. doi:https://doi.org/10.1016/j.prp.2020.152859.
- Horm TM, Schroeder JA. MUC1 and metastatic cancer: expression, function and therapeutic targeting. Cell Adh Migr. 2013; 7(2):187–198. doi:https://doi.org/10.4161/cam.23131.
- Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P. Tumour-associated carbohydrate antigens in breast cancer . Breast Cancer Res. 2010;12(3):204–216. doi:https://doi.org/10.1186/bcr2577.
- Woodman N, Pinder SE, Tajadura V, Le Bourhis X, Gillett C, Delannoy P, et al. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer. Int J Oncol. 2016;49(1):265–275.
- Koh YW, Lee HJ, Ahn J-H, Lee JW, Gong G. Expression of Lewis X is associated with poor prognosis in triple-negative breast cancer. Am J Clin Pathol. 2013;139(6):746–53. doi:https://doi.org/10.1309/AJCP2E6QNDIDPTTC.
- Krathen RA, Orengo IF, Rosen R. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96(2):164–167.
- Cordone I, Masi S, Summa V, Carosi M, Vidiri A, Fabi A, et al. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study. Breast Cancer Res. 2017;19(1):46. doi:https://doi.org/10.1186/s13058-017-0827-4.
- Fazakas C, Wilhelm I, Nagyoszi P, Farkas AE, Haskó J, Molnár J, et al. Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS One. 2011;6(6):e20758. doi:https://doi.org/10.1371/journal.pone.0020758.
- Nolte SM, Venugopal C, McFarlane N, Morozova O, Hallett RM, O’Farrell E, et al. A cancer stem cell model for studying brain metastases from primary lung cancer. J Natl Cancer Inst. 2013;105(8):551–562. doi:https://doi.org/10.1093/jnci/djt022.
- Mordoh J, Leis S, Bravo AI, Podhajcer OL, Ballare C, Capurro M, et al. Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias. Int J Biol Markers. 1994;9(3):125–134. doi:https://doi.org/10.1177/172460089400900301.
- Mordoh J, SIlva C, Albarellos M, Bravo AI, Kairiyama C. Phase I clinical trial in cancer patients of a new monoclonal antibody FC-2.15 reacting with tumor proliferating cells. J Immunother Emphasis Tumor Immunol. 1995;17(3):151–160.
- Skubitz KM, Snook Robert W. II. Monoclonal antibodies that recognize lacto-N-fucopentaose III (CD15) react with the adhesion-promoting glycoprotein family (LFA-1/HMAC-1/GP150,95) and CR1 on human neutrophils. J Immunol. 1987;139(5):1631–1639.
- Ostrand Rosenberg S, Fenselau C. Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. J Immunol. 2018;200(2):422–431. doi:https://doi.org/10.4049/jimmunol.1701019.
- Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res. 2017;5(1):3–8. doi:https://doi.org/10.1158/2326-6066.CIR-16-0297.
- Pyzer AR, Cole L, Rosenblatt J, Avigan DE. Myeloid-derived suppressor cells as effectors of immune suppression in cancer. Int J Cancer. 2016;139(9):1915–1926. doi:https://doi.org/10.1002/ijc.30232.
- Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, et al. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest. 2011;121(10):4015–4029. doi:https://doi.org/10.1172/JCI45862.
- Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, et al. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4 + CD25 + FoxP3+ Tregs from CD4 + CD25-FoxP3- T cells. J Leukoc Biol. 2012;92(5):987–997. doi:https://doi.org/10.1189/jlb.0911465.
- Gorgun GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J, et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood. 2013;121(15):2975–2987. doi:https://doi.org/10.1182/blood-2012-08-448548.
- Jiang H, Gebhardt C, Umansky L, Beckhove P, Schulze TJ, Utikal J, Umansky V. Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients. Int J Cancer. 2015;136(10):2352–2360. doi:https://doi.org/10.1002/ijc.29297.
- Zhang H, Li ZL, Ye SB, Ouyang LY, Chen YS, He J, Huang HQ, et al. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator. Cancer Immunol Immunother. 2015;64(12):1587–1599. doi:https://doi.org/10.1007/s00262-015-1765-6.
- Horinaka A, Sakurai D, Ihara F, Makita Y, Kunii N, Motohashi S, et al. Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer. Cancer Sci. 2016;107(3):207–216. doi:https://doi.org/10.1111/cas.12866.
- Cha YJ, Koo JS. Role of tumor-associated myeloid cells in breast cancer. Cells. 2020;9(8):1785. doi:https://doi.org/10.3390/cells9081785.
- Goedegebuure P, Mitchem JB, Porembka MR, Tan MCB, Belt BA, A. Wang-Gillam A, et al. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. Curr Cancer Drug Targets. 2011;11(6):734–751. doi:https://doi.org/10.2174/156800911796191024.
- Azuma Y, Ito M, Taniguchi A, Matsumoto K. Expression of cell surface Lewis X and Y antigens and FUT4 mRNA is increased in Jurkat cells undergoing apoptosis. Biochim Biophys Acta. 2004;1672(3):157–163. doi:https://doi.org/10.1016/j.bbagen.2004.03.006.
- van Die I, van Vliet SJ, Kwame Nyame A, Cummings RD, Bank CMC, Appelmelk B, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology . 2003;13(6):471–478. doi:https://doi.org/10.1093/glycob/cwg052.
- Engering A, Geijtenbeek TBH, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol. 2002;168 (5):2118–2126. doi:https://doi.org/10.4049/jimmunol.168.5.2118.
- Chen H, Yuan B, Zheng Z, Liu Z, Wang S. Lewis X oligosaccharides-heparanase complex targeting to DCs enhance antitumor response in mice. Cell Immunol. 2011; 269(2):144–148. doi:https://doi.org/10.1016/j.cellimm.2011.03.021.
- Lukas L, Fernando M, Grunow D, Kannicht K, Horst A, Nollau P, Wagener C. Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiol. 2005;15(1):87–100. doi:https://doi.org/10.1093/glycob/cwh139.
- Bogoevska V, Horst A, Klampe B, Lothar L, Wagener C, Nollau P. CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via Lewis x residues. Glycobiology. 2006;16(3):197–209. doi:https://doi.org/10.1093/glycob/cwj057.